The Clinical Efficacy and Tolerability of a Novel Retinaldehyde Serum with Firming Peptides to Improve Skin Texture and Signs of Photoaging

November 2024 | Volume 23 | Issue 11 | 992 | Copyright © November 2024


Published online October 23, 2024

doi:10.36849/JDD.8058R1 

Hailey Konisky BSa, Whitney P. Bowe MDb,c, Pada Yang BSc, Kseniya Kobets MD MHSa

aAlbert Einstein College of Medicine, Bronx, NY
bIcahn School of Medicine at Mount Sinai, New York, NY
cDr. Whitney Bowe Beauty, Greenwich, CT

Abstract

Retinoids are derivatives of vitamin A prominently used in cosmeceuticals to reverse signs of photoaging. Retinaldehyde (retinal) is 10x more bioavailable than retinol and is gaining traction in the skincare industry for being the strongest over-the-counter retinoid. This study evaluated the efficacy and tolerability of a novel retinal formulation including peptides, ceramides, and lipids, designed to sustain the potency of the retinal and enhance delivery to reverse clinical signs of photoaging. This study was a trial of the test product (Retinal Night Advanced 0.1% Retinal Firming Treatment, Dr. Whitney Bowe Beauty, Greenwich, CT) in which 32 female subjects were enrolled. 47% of subjects had skin of color (Fitzpatrick Skin Type III-VI) and 57% had sensitive skin. Subjects applied the test product 3 nights weekly to the face, neck, and chest for 8 weeks. Fine lines of the face had 12% visible change by week 8 (P<0.0001). Fine lines on the chest showed progressive visible improvement of 11% at week 2 (P=0.0005) and 19% at week 8 (P<0.0001). There was a 19% improvement in visible hyperpigmentation of the face by the 8-week mark (P<0.0001). Visible texture of the face improved by 5% (P=0.0078) and pores improved by 20% at week 8 (P<0.0001). Patch testing revealed no signs of sensitization or irritation. This clinical study demonstrates that this retinal formulation is safe, well-tolerated, and effective in improving the appearance of fine lines, hyperpigmentation, texture, and pores.

J Drugs Dermatol. 2024;23(11):992-997. doi:10.36849/JDD.8058R1 

INTRODUCTION

Retinoids are derivatives of Vitamin A used to treat myriad dermatological conditions including acne, psoriasis, and skin cancer. They are also prominently used in skincare as an "anti-aging" treatment in various concentrations and forms. All-trans retinoic acid, commonly known as tretinoin, is available by prescription and is the most widely investigated retinoid for photoaging. All-trans retinoic acid regulates over 3000 genes in keratinocytes and fibroblasts, and when these receptors are activated, it can increase cell turnover and motility, increase synthesis of procollagen and glycosaminoglycans, and inhibit matrix metalloproteinases.1,2 Retinoic acid precursors including retinyl esters, retinol, and retinaldehyde (aka retinal) are available over the counter. These precursors require enzymatic conversion in the skin prior to becoming retinoic acid, the bioactive form, and thus are considered less potent but also less irritating than retinoic acid. The potency of the retinoid inversely correlates with the number of in vivo chemical conversions necessary to create all-trans retinoic acid. Retinal specifically has been gaining traction in the skincare industry for being the most potent retinoid available without a prescription.

As we age, the skin loses its proliferative capacity and becomes thinner, drier, and less elastic. The use of retinoids has been shown to increase epidermal proliferation and increase the deposition of glycosaminoglycans, essentially reversing these signs of aging. All-trans retinoic acid has been studied extensively for its ability to drive measurable clinical improvements in photoaging and overall appearance of the skin after several months of consistent use. Though tretinoin is the strongest retinoid, it can cause significant erythema, irritation, burning, or dermatitis, often causing patients to discontinue use.2 The most dramatic benefits in terms of photoaging are often appreciated after 6 months of consistent use, and consequently, there is great demand for retinoids that are effective but better tolerated.2 Retinol requires 2 conversion steps to become retinoic acid and is considered 20 times less potent than tretinoin. 

Nonetheless, retinol has been shown to improve signs of photoaging with less transepidermal water loss, erythema, and scaling of the skin than tretinoin.2 Retinal, on the other hand, only requires 1 conversion step to become retinoic acid, making it the strongest over-the-counter retinoid.3 Retinal has been